Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupixent for Airway Inflammation and Mucus Plugging in COPD (Japan)
jRCT2061250087Recruiting
- Sponsor
- Sanofi
- Start
- Jul 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Dupilumab with Placebo (2 arms). Primary endpoint: Change from baseline to Week 24 in global lung mucus score (UCSF mucus scoring). Started Jul 2026; status: recruiting.
02
Drugs
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2061250087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2061250087.